MONDAY, Nov. 7, 2022 (HealthDay News) — Infants and children sick with RSV are flooding pediatricians’ offices and children’s hospitals across the United States, due to an early surge of the common childhood virus this year. But within one or two “sick seasons,” doctors expect to have on hand long-soughtContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%. The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir,Continue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — Getting an updated booster for COVID-19 is likely to boost protection substantially, according to a new study released by drug company Pfizer on Friday. The news affirms a decision by the U.S. Food and Drug Administration to OK the bivalent booster without firstContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options. GSK has developed a new antibiotic to treat urinary tract infections (UTIs) that appears to be so effective the pharmaceutical company stopped testing early on the recommendationContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer’s treatment in Black patients. It did not show the same benefit in white people. Learning how people from different ethnic groups respond to the same drugContinue Reading
THURSDAY, Nov. 3, 2022 — U.S. doctors prescribing opioids for pain relief now have a new — and more nuanced — set of guidelines from the federal government. Issued by the U.S. Centers for Disease Control and Prevention on Thursday, the new recommendations incorporate new science developed since the lastContinue Reading
WEDNESDAY, Nov. 2, 2022 (HealthDay News) — Years of litigation over the opioid epidemic could end soon, as the national pharmacy chains CVS and Walgreens announced Wednesday that each company has agreed to a nearly $5 billion settlement. While neither of the companies admitted wrongdoing, the settlements are part ofContinue Reading
WEDNESDAY, Nov. 2, 2022 (HealthDay News) — New research reveals that the brain is much more flexible than once thought and can change rapidly during treatment for major depression. People receiving inpatient treatment for major depression had increased brain connectivity after just six weeks, German researchers report. They compared brainContinue Reading
TUESDAY, Nov. 1, 2022 (HealthDay News) — Doctors could soon have access to a new weapon in the ongoing battle against antibiotic-resistant bacteria. An experimental combination antibiotic appears to offer a new option for doctors treating stubborn drug-resistant urinary tract infections (UTIs), according to new clinical trial results. The newContinue Reading
MONDAY, Oct. 31, 2022 (HealthDay News) – It could be harder to fill a prescription for the widely used antibiotic amoxicillin because of a shortage that appears to be linked to an ongoing surge in RSV infections across the United States. Supplies of amoxicillin oral solution, which is typically usedContinue Reading